✦ LIBER ✦

Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise

✍ Scribed by Kaku, K.; Kiyosue, A.; Inoue, S.; Ueda, N.; Tokudome, T.; Yang, J.; Langkilde, A. M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of canagliflozin mon

✍ Stenlöf, K.; Cefalu, W. T.; Kim, K.-A.; Alba, M.; Usiskin, K.; Tong, C.; Canovat 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 832 KB

Dapagliflozin Monotherapy in Type 2 Diab

✍ Ferrannini, E.; Ramos, S. J.; Salsali, A.; Tang, W.; List, J. F. 📂 Article 📅 2010 🏛 American Diabetes Association 🌐 English ⚖ 326 KB

Efficacy and safety of canagliflozin mon

✍ Inagaki, Nobuya; Kondo, Kazuoki; Yoshinari, Toru; Takahashi, Nahoko; Susuta, Yut 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 708 KB

Efficacy and safety of sitagliptin monot

✍ Kenji Nonaka; Taro Kakikawa; Asako Sato; Kotoba Okuyama; Go Fujimoto; Naoki Kato 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 405 KB

Long-term efficacy and safety of canagli

✍ Stenlöf, Kaj; Cefalu, William T.; Kim, Kyoung-Ah; Jodar, Esteban; Alba, Maria; E 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 737 KB

Efficacy and safety of the dipeptidyl pe

✍ R. E. Pratley; M. S. Kipnes; P. R. Fleck; C. Wilson; Q. Mekki; Alogliptin Study 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 157 KB